As of August 20, 2026, the most significant confirmed development in the Zantac litigation is a Delaware Superior Court ruling issued April 13, 2026, which granted summary judgment against roughly 80,000 pending Zantac cases in that state after finding plaintiffs did not meet Delaware’s causation standard — effectively closing those Delaware claims. Separately, the federal appeal before the Eleventh Circuit, which challenges the 2022 ruling that excluded plaintiffs’ expert witnesses, remains undecided; the court heard oral arguments in October 2025 but has not yet issued a ruling. State court litigation continues in California, Illinois, and other jurisdictions outside Delaware.
Last updated: August 2026
The Zantac lawsuit is alive and active in 2026, despite what you may have heard about federal court dismissals. Thousands of people who took this heartburn drug and later developed cancer are filing claims in state courts across America.
The core allegation remains unchanged: Zantac contained NDMA, a probable human carcinogen, and manufacturers knew or should have known about it. Federal judges dismissed many cases in 2022 based on scientific evidence disputes. But state courts operate under different rules.
You will learn exactly who can file a claim right now, what settlement amounts look like, and the specific deadlines you cannot miss. Over 70,000 lawsuits were originally filed, and new ones continue in states like California, Illinois, and Delaware.
Payouts vary wildly based on cancer type and usage history. Some estimates suggest individual settlements could range from $50,000 to over $500,000 for severe cases.
Zantac Lawsuit 2026: What You Need to Know Now
The Zantac lawsuit in 2026 centers on state court litigation after federal MDL dismissals reshaped the legal path forward. Plaintiffs are now pursuing claims through individual state courts rather than one centralized federal proceeding.
Here is the current situation. The federal multidistrict litigation, known as MDL 2924, saw massive setbacks in December 2022. Judge Robin Rosenberg excluded plaintiff expert witnesses, essentially gutting the scientific foundation of federal cases. This led to widespread dismissals.
But dismissal in federal court does not mean the end. State courts have different evidentiary standards. Many states use more lenient rules for expert testimony. This opened doors that seemed closed.
| 2026 Lawsuit Status | Details |
|---|---|
| Federal MDL Status | Effectively dismissed since 2022 |
| Active State Court Venues | California, Delaware, Illinois, Pennsylvania |
| New Filings Accepted | Yes, in most state courts |
| Number of Active Cases | Estimated 4,000+ in state courts |
The defendants include major pharmaceutical players. Sanofi, GlaxoSmithKline, Boehringer Ingelheim, and Pfizer all face ongoing litigation.
Your ability to file depends heavily on your state’s statute of limitations. Some states have already closed their filing windows. Others remain open through late 2026 or beyond.
Zantac Class Action Lawsuit Explained
A Zantac class action lawsuit is a legal action where multiple plaintiffs with similar claims sue defendants together as a single group. However, most current Zantac litigation is not technically a class action.
This distinction matters for your payout expectations. True class actions divide settlement funds among all class members, often resulting in smaller individual payments. Mass tort litigation, which describes most Zantac cases, treats each plaintiff’s case individually.
Here is what that means for you. Your settlement amount depends on your specific injuries, usage duration, and evidence strength. Someone who took Zantac for 15 years and developed bladder cancer will receive different consideration than someone who used it briefly.
The original Zantac litigation began as an MDL, not a class action. An MDL consolidates similar federal cases for pretrial proceedings but keeps individual cases separate for trial purposes.
| Class Action vs Mass Tort | Class Action | Mass Tort (Zantac) |
|---|---|---|
| Individual Case Assessment | No | Yes |
| Settlement Determination | Equal shares | Based on damages |
| Plaintiff Control | Limited | More personal involvement |
| Typical Payout | Lower per person | Higher per person |
Some consumer refund class actions did proceed separately. These covered people who purchased Zantac but did not develop cancer. Payouts for those cases were minimal, often under $10.
The cancer cases are where significant money exists. These require individual proof of injury, causation, and damages.
Class Action Lawsuit Against Zantac Manufacturers
The class action lawsuit against Zantac manufacturers targets companies that made, marketed, and sold ranitidine products containing NDMA contamination. Multiple corporate defendants face liability across different market segments.
Sanofi holds primary responsibility for branded Zantac sold in the United States for decades. The company acquired Zantac rights through corporate mergers and continued selling it until the FDA requested recalls.
GlaxoSmithKline originally developed and patented ranitidine in the 1970s. Though they sold the brand rights years ago, plaintiffs argue they knew about NDMA risks during their ownership period.
Boehringer Ingelheim marketed and distributed Zantac during certain periods. Their involvement exposes them to claims from users during their distribution window.
| Defendant | Role | Primary Liability Period |
|---|---|---|
| Sanofi | Final brand owner | 2017 to 2020 |
| GlaxoSmithKline | Original developer | 1983 to 2006 |
| Boehringer Ingelheim | Marketer/Distributor | 2006 to 2017 |
| Pfizer | Store brand supplier | Various years |
| Dr. Reddy’s | Generic manufacturer | 2000s to 2020 |
Generic ranitidine manufacturers also face lawsuits. Companies like Dr. Reddy’s Laboratories, Apotex, and Amneal Pharmaceuticals produced store-brand versions sold at CVS, Walgreens, and Walmart.
The legal theory is straightforward. All defendants allegedly knew or should have known that ranitidine molecules were inherently unstable and could form NDMA.
Key Takeaway: Multiple pharmaceutical giants face ongoing Zantac litigation in state courts, with each defendant potentially liable for different time periods of your Zantac use.
Lawsuit Against Zantac: Who Is Being Sued
The lawsuit against Zantac names pharmaceutical manufacturers, distributors, and retailers as defendants in various cases. Your specific defendants depend on which Zantac products you purchased and when.
Brand name Zantac users primarily sue Sanofi. If you bought Zantac in its familiar packaging from any store between 2017 and 2020, Sanofi manufactured that product.
Generic ranitidine expands the defendant list considerably. Store brands often came from different manufacturers than branded products. CVS ranitidine, Walgreens ranitidine, and Walmart Equate ranitidine each have traceable supply chains.
Here is why this matters for your case:
- Multiple defendants increase settlement potential. More companies at the table often means more money available.
- Different defendants have different financial resources. A judgment against a small generic maker is worth less than one against Sanofi.
- Liability periods vary. You can only sue companies responsible for products during your usage timeline.
Retailers themselves face lawsuits in some jurisdictions. Theories include failure to warn, negligent product selection, and breach of implied warranty. These claims face higher legal hurdles than manufacturer liability claims.
The pharmacy chains selling store-brand ranitidine marketed it as equivalent to Zantac. Plaintiffs argue this marketing creates shared responsibility for NDMA exposure.
Your attorney will identify the correct defendants based on purchase records, usage timeline, and available evidence. Many people used both brand name and generic versions over the years.
Zantac Lawsuit Settlement Amounts in 2026
Zantac lawsuit settlement amounts in 2026 remain speculative because no global settlement exists yet. Individual settlements and verdicts in state courts provide the best guidance for expectations.
The settlement landscape is fragmented. Unlike resolved mass torts with clear payout grids, Zantac litigation continues evolving. State court cases proceed individually, with each outcome influencing future negotiations.
Here are projected settlement tiers based on case severity:
| Settlement Tier | Cancer Type | Estimated Range |
|---|---|---|
| Tier 1 (Highest) | Bladder, Stomach Cancer | $200,000 to $550,000 |
| Tier 2 | Liver, Esophageal Cancer | $150,000 to $350,000 |
| Tier 3 | Prostate, Breast Cancer | $75,000 to $200,000 |
| Tier 4 | Other Linked Cancers | $50,000 to $150,000 |
| Wrongful Death | Any Cancer Type | $300,000 to $750,000+ |
These estimates reflect legal analyst projections and comparable pharmaceutical settlements. Actual amounts will depend on trial outcomes in bellwether state court cases.
Factors pushing amounts higher include:
- Long duration of Zantac use (10+ years)
- Prescription strength usage
- Young age at cancer diagnosis
- Strong medical documentation
- Clear purchase records
Settlement negotiations intensify when defendants lose early trials. Defense verdicts slow momentum. The next 12 months of state court results will largely determine where amounts land.
Zantac Lawsuit Payout Per Person Estimates
Zantac lawsuit payout per person depends entirely on individual case factors, with no standard amount applying to all claimants. Cancer type, usage duration, and provable damages drive individual valuations.
Think of it like car accident settlements. Someone with a broken arm receives less than someone paralyzed. Zantac cases follow similar logic. The severity of your cancer and its impact on your life determines your case value.
Critical factors affecting your payout:
- Cancer diagnosis: Bladder and stomach cancers command highest values
- Treatment costs: Documented medical expenses become part of damages
- Lost income: Career disruption from cancer treatment adds value
- Pain and suffering: Subjective but significant damage category
- Survival status: Wrongful death cases for deceased family members often settle higher
Someone who took Zantac briefly and developed an early-stage, treatable cancer may receive $50,000 to $100,000. A long-term user who died from aggressive bladder cancer leaves a family potentially eligible for $500,000 or more.
Medical records are everything. Your oncologist’s documentation linking cancer type to known NDMA pathways strengthens your case dramatically.
Purchase records help but are not always essential. Pharmacy records, insurance claims, and even credit card statements can establish Zantac usage. Many attorneys accept cases based on credible patient testimony about usage history.
Key Takeaway: Individual payouts vary from $50,000 to over $500,000 based on cancer severity, usage duration, and documentation quality.
Who Qualifies for the Zantac Lawsuit
Who qualifies for the Zantac lawsuit includes anyone diagnosed with certain cancers after regularly using Zantac or generic ranitidine products. The connection between your usage and your diagnosis is the key requirement.
Qualifying typically requires meeting these basic criteria:
- Used Zantac or generic ranitidine for at least one year
- Diagnosed with a cancer linked to NDMA exposure
- Diagnosis occurred after sufficient exposure period
- Within your state’s statute of limitations for filing
Cancers generally accepted in Zantac lawsuits:
| Cancer Type | Connection Strength | Case Acceptance |
|---|---|---|
| Bladder Cancer | Strong | Widely accepted |
| Stomach Cancer | Strong | Widely accepted |
| Liver Cancer | Moderate to Strong | Commonly accepted |
| Esophageal Cancer | Moderate | Commonly accepted |
| Prostate Cancer | Moderate | Accepted with evidence |
| Breast Cancer | Moderate | Accepted with evidence |
| Pancreatic Cancer | Under review | Case by case |
| Colorectal Cancer | Under review | Case by case |
Family members of deceased Zantac users may file wrongful death claims. Surviving spouses, children, and sometimes parents can pursue these cases on behalf of loved ones who died from qualifying cancers.
Your age at diagnosis matters too. Younger cancer patients with no family history present compelling cases because NDMA exposure offers a plausible explanation for otherwise unexpected diagnoses.
Prior smokers face harder battles. Defense attorneys argue smoking caused the cancer. However, combined exposure theories allow many former smokers to proceed.
Zantac Lawsuit Eligibility Requirements
Zantac lawsuit eligibility requirements go beyond basic qualification to include documentation standards and timing rules that can make or break your case. Attorneys evaluate multiple factors before accepting cases.
Here is what lawyers look for when assessing your eligibility:
Documentation Checklist:
- Medical records confirming cancer diagnosis
- Pathology reports specifying cancer type
- Treatment records showing procedures, chemotherapy, radiation
- Pharmacy records or prescription history
- Any evidence of Zantac/ranitidine purchase or use
The documentation gap worries some potential plaintiffs. Zantac was sold over-the-counter, meaning no prescription trail exists for many users. Attorneys have adapted their evidence standards to address this reality.
Credible testimony about regular usage often suffices. If you consistently bought Zantac at the same store for years, you may have loyalty program records. Old photographs showing Zantac bottles in your medicine cabinet help.
| Eligibility Factor | Strong Case | Weak Case |
|---|---|---|
| Usage Duration | 5+ years documented | Under 1 year |
| Cancer Type | Bladder, stomach | Unrelated cancer |
| Documentation | Pharmacy records available | No records, vague memory |
| Timing | Diagnosis after extended use | Diagnosis before significant use |
| Other Risk Factors | None or minimal | Heavy smoker, family history |
State residency affects where you can file. You generally file in the state where you lived during Zantac use or where you currently reside. Some states offer better legal environments than others.
Attorneys offer free case evaluations. Take advantage of these consultations to understand your specific eligibility before assuming you cannot participate.
Zantac and Cancer Link: The Science
The Zantac and cancer link stems from NDMA contamination in ranitidine, the active ingredient. NDMA is classified as a probable human carcinogen by multiple health agencies worldwide.
NDMA stands for N-Nitrosodimethylamine. This chemical compound damages DNA and causes tumors in laboratory animals. Human epidemiological studies suggest similar cancer-causing potential.
The contamination problem is unique to ranitidine’s molecular structure. Unlike manufacturing defects that could be fixed, the ranitidine molecule itself appears inherently unstable. It degrades into NDMA under common storage conditions.
Key scientific findings:
- Ranitidine converts to NDMA when exposed to heat
- Higher temperatures accelerate NDMA formation
- Storage in cars, warehouses, or hot environments increases contamination
- Human body temperature may trigger additional conversion after ingestion
The FDA discovered unacceptable NDMA levels during independent testing in 2019. Initial findings showed some pills contained over 3,000 times the acceptable daily NDMA limit. This triggered the April 2020 market withdrawal request.
| Scientific Evidence Point | What It Shows |
|---|---|
| Valisure Testing (2019) | NDMA levels up to 3,389,000 ng per tablet |
| FDA Daily Limit | 96 ng NDMA per day |
| Stanford Study | Ranitidine users showed 400x higher NDMA urine levels |
| Animal Studies | Liver, bladder, lung tumors in rodents |
The legal battle centers on causation. Defendants argue that human studies do not definitively prove ranitidine causes cancer in people. Plaintiffs counter that the mechanism is clear, and waiting for decades of human data is unreasonable.
State courts applying different scientific evidence standards have allowed these cases to proceed where federal courts would not.
Key Takeaway: NDMA contamination in Zantac is scientifically documented, but proving it caused your specific cancer remains the central legal challenge.
How to File a Zantac Lawsuit in 2026
Filing a Zantac lawsuit in 2026 requires selecting an experienced attorney, gathering documentation, and submitting your case to the appropriate state court. The process takes months to initiate and years to resolve.
Step 1: Find a Qualified Attorney
Look for lawyers with specific Zantac or pharmaceutical mass tort experience. Many firms offer free consultations and work on contingency, meaning no upfront costs. They collect fees only if you win.
Step 2: Gather Your Documentation
Before your consultation, collect:
- All medical records related to your cancer diagnosis
- Pharmacy records or prescription history
- Any receipts or purchase records for Zantac products
- Insurance claim records mentioning ranitidine
- Written timeline of your Zantac usage history
Step 3: Complete Your Case Evaluation
Your attorney will review your documentation, assess case strength, and explain your options. This typically takes one to two weeks.
Step 4: Sign Retainer Agreement
If your attorney accepts your case, you sign paperwork authorizing them to represent you. Read fee structures carefully. Standard contingency fees range from 33% to 40% of any settlement.
Step 5: Case Filing
Your attorney prepares and files a complaint in the appropriate state court. You receive copies of all filed documents.
| Filing Timeline | Expected Duration |
|---|---|
| Initial Consultation | 1 to 2 hours |
| Document Gathering | 2 to 4 weeks |
| Case Evaluation | 1 to 2 weeks |
| Complaint Drafting | 2 to 4 weeks |
| Court Filing | 1 week |
| Total to File | 6 to 11 weeks |
After filing, the discovery process begins. This involves exchanging evidence with defendants, depositions, and expert witness preparation. Most cases take two to four years from filing to resolution.
Zantac Lawsuit Deadline 2026: Key Dates
The Zantac lawsuit deadline in 2026 varies by state, with some statutes of limitations expiring this year and others extending further. Missing your deadline permanently bars your claim.
Statutes of limitations for personal injury cases typically run two to six years from diagnosis or discovery of harm. For Zantac cases, most courts start the clock when you learned or should have learned that Zantac may have caused your cancer.
The FDA recall announcement in April 2020 creates a common knowledge trigger date. Some courts rule that anyone diagnosed after 2020 should have reasonably connected Zantac to their cancer within a certain timeframe.
State Deadline Overview for 2026:
| State | Statute of Limitations | 2026 Status |
|---|---|---|
| California | 2 years from discovery | Depends on diagnosis date |
| Delaware | 2 years from injury | Depends on diagnosis date |
| Illinois | 2 years from discovery | Depends on diagnosis date |
| Pennsylvania | 2 years from discovery | Depends on diagnosis date |
| Florida | 4 years from discovery | More time available |
| Texas | 2 years from discovery | Depends on diagnosis date |
| New York | 3 years from discovery | Varies by case |
If you were diagnosed with cancer in 2024 and live in California, your deadline hits in 2026. Waiting until 2027 would bar your claim entirely.
Do not wait to check your deadline. Contact an attorney immediately if you have any concerns about timing. Many people lose valid claims simply because they delayed too long.
Some states allow tolling, which pauses the deadline under certain circumstances. Minor children and mentally incapacitated individuals often receive extended deadlines.
Is the Zantac Lawsuit Still Open
The Zantac lawsuit is still open for new claimants in 2026 through state court systems despite federal MDL effectively shutting down. Your ability to file depends primarily on your state’s statute of limitations.
The confusion about case status stems from the December 2022 federal court rulings. Judge Robin Rosenberg’s decision to exclude plaintiff scientific experts devastated federal cases. Media headlines declared the litigation dead. That was not accurate.
Here is what actually happened and what it means for you:
Federal MDL Status: The multidistrict litigation in the Southern District of Florida no longer accepts new cases. Pending cases were dismissed or sent back to original filing courts. No path forward exists in federal court.
State Court Status: State courts across America continue accepting and prosecuting Zantac cases. California, Delaware, Illinois, and Pennsylvania have active dockets with thousands of cases.
| Court System | Accepting New Cases | Active Litigation |
|---|---|---|
| Federal MDL 2924 | No | No |
| California State | Yes | Yes |
| Delaware State | Yes | Yes |
| Illinois State | Yes | Yes |
| Pennsylvania State | Yes | Yes |
| Other States | Varies | Check locally |
Why do state courts matter now? Different rules for scientific evidence. Federal courts apply the Daubert standard strictly. Some state courts use the older Frye standard or apply Daubert more flexibly.
The same expert testimony rejected in federal court may be accepted in state court. This gives plaintiffs a viable path to trial and potential settlements.
Key Takeaway: Federal Zantac litigation ended, but state court cases proceed actively with new filings still accepted in multiple jurisdictions.
Zantac MDL Update for 2026
The Zantac MDL update for 2026 confirms that federal multidistrict litigation remains closed with no realistic revival path. MDL 2924 in the Southern District of Florida handles only administrative cleanup matters.
Understanding what happened to the MDL explains the current legal environment. Over 70,000 cases consolidated before Judge Robin Rosenberg starting in 2020. Plaintiffs expected coordinated pretrial proceedings to streamline the path to settlements or trials.
The December 2022 Daubert hearings changed everything. Judge Rosenberg ruled that plaintiff expert witnesses could not reliably testify that Zantac causes cancer in humans. Without expert testimony, cases cannot survive summary judgment.
Timeline of MDL Collapse:
| Date | Event |
|---|---|
| February 2020 | MDL 2924 established |
| December 2022 | Daubert ruling excludes plaintiff experts |
| January 2023 | Bellwether trials cancelled |
| 2023 to 2024 | Mass dismissals and remands |
| 2025 to 2026 | Administrative wind-down only |
Some federal cases were remanded to original district courts. Others were dismissed with prejudice, meaning they cannot be refiled. The specific outcome depended on individual case postures and timing.
Appeals of the Daubert ruling were unsuccessful. The Eleventh Circuit declined to overturn Judge Rosenberg’s evidentiary determinations, which are typically given significant deference on appeal.
For practical purposes, federal courts are not a viable avenue for Zantac claims. New cases must go through state court systems where different evidentiary rules apply.
Zantac Settlement Update 2026
The Zantac settlement update for 2026 shows no global settlement agreement but increasing pressure on defendants as state court cases advance toward trial. Several factors point toward eventual resolution.
Global settlements in pharmaceutical mass torts typically occur after defendants lose multiple trials. With federal litigation shut down, state court outcomes now drive settlement dynamics.
Current Settlement Landscape:
- No comprehensive settlement fund exists
- Defendants continue fighting individual cases
- State court trial dates are scheduled throughout 2026
- Private settlements in individual cases remain confidential
Defense strategy focuses on winning enough cases to discourage plaintiffs. If defendants prevail in early state court trials, settlement pressure decreases. Plaintiff victories accelerate negotiations.
| Settlement Scenario | Likelihood in 2026 | Impact |
|---|---|---|
| Global settlement announced | Low to moderate | All qualifying claimants receive offers |
| State court trial victories | Moderate | Increases settlement pressure |
| Additional defense wins | Moderate | Delays any settlement talks |
| Individual private settlements | Ongoing | Case by case resolution |
What should you do while waiting? File your case to preserve your claim. Get in line before any potential settlement deadline emerges. Once a global settlement is announced, filing windows often close quickly.
Attorneys continue accepting new cases specifically because settlement remains possible. They would not invest resources in cases with no potential resolution path.
The lack of a current settlement does not mean one will never happen. It means timing remains uncertain. Being a filed plaintiff puts you in position to benefit when resolution occurs.
Zantac State Court Lawsuits Explained
Zantac state court lawsuits are now the primary litigation path for cancer victims seeking compensation. These cases operate independently of the failed federal MDL and follow each state’s procedural rules.
State courts offer critical advantages for Zantac plaintiffs. The biggest benefit involves evidentiary standards for scientific expert testimony.
Federal vs State Evidence Standards:
| Standard | Courts Using It | Strictness |
|---|---|---|
| Daubert (strict) | Federal, most states | High |
| Frye | California, Illinois, others | Moderate |
| Daubert (flexible) | Some state courts | Lower |
Under Frye, expert testimony is admissible if it is generally accepted in the relevant scientific community. Under Daubert, judges act as gatekeepers evaluating methodology rigorously. The same expert rejected under strict Daubert may qualify under Frye.
California presents the most promising venue. The state’s large population means many plaintiffs. Its Frye-based standard for expert testimony creates a friendlier environment for Zantac cases.
Delaware matters because many pharmaceutical companies incorporate there. Special procedures exist for complex litigation involving Delaware-incorporated defendants like Sanofi.
Key State Court Venues:
- California: Coordinated proceedings in San Francisco Superior Court
- Delaware: Superior Court Complex Commercial Litigation Division
- Illinois: Cook County Circuit Court
- Pennsylvania: Philadelphia Court of Common Pleas
Each venue has different procedural timelines. California cases may take three to four years from filing to trial. Delaware moves somewhat faster with dedicated commercial litigation judges.
Your attorney will recommend the best venue based on your residency, the defendants in your case, and strategic considerations about jury pools and case law.
Key Takeaway: State courts now control Zantac litigation outcomes, with California and Delaware emerging as the most active and promising venues.
Class Action Lawsuit Zantac: Your Options
Your options in the Zantac class action lawsuit situation depend on whether you have a cancer diagnosis or simply purchased the product. Different legal paths exist for each scenario.
If You Have Cancer:
Individual mass tort litigation, not class action participation, is your path. File through an attorney handling Zantac state court cases. Your case will be evaluated individually based on your diagnosis, usage, and damages.
Benefits of individual filing:
- Settlement based on your specific injuries
- Personal attorney attention
- Higher potential payout than class action shares
- Control over settlement acceptance
If You Purchased Zantac But Have No Cancer:
Consumer class actions for purchase refunds may exist in some states. These cases seek to recover purchase costs from people who bought a defective product. Payouts are typically small, often under $25 per class member.
Check class action settlement websites for open Zantac consumer claims. Registration is usually simple, requiring proof of purchase or just a declaration of purchase.
| Your Situation | Recommended Action | Potential Value |
|---|---|---|
| Cancer diagnosis | Individual lawsuit | $50,000 to $500,000+ |
| Family member died from cancer | Wrongful death lawsuit | $300,000 to $750,000+ |
| Purchased Zantac, no illness | Consumer class action | Under $25 |
| Purchased and have non-cancer illness | Consult attorney | Varies |
The distinction between class action and mass tort is not academic. It directly affects how much money you might receive.
Do not assume you cannot file because you missed some deadline. Different deadlines apply to different types of claims. An attorney consultation costs nothing and provides clarity about your specific options.
Frequently Asked Questions
How much money can I get from the Zantac lawsuit?
Payouts range from $50,000 to over $500,000 depending on your cancer type and case strength.
Bladder and stomach cancer cases command the highest values.
Documentation quality and usage duration significantly affect individual settlement amounts.
What cancers qualify for the Zantac lawsuit?
Bladder cancer, stomach cancer, liver cancer, and esophageal cancer are most commonly accepted.
Prostate cancer, breast cancer, and pancreatic cancer cases are evaluated individually.
Your oncologist’s records connecting your specific cancer to NDMA pathways strengthen qualification.
Is there a deadline to file a Zantac lawsuit in 2026?
Yes, each state has different statutes of limitations, typically two to four years from diagnosis or discovery.
Some 2024 diagnoses face 2026 deadlines in states with two-year statutes.
Contact an attorney immediately to determine your specific deadline.
Can I still file a Zantac lawsuit after the MDL was dismissed?
Yes, state courts continue accepting new Zantac cases despite federal MDL dismissals.
California, Delaware, Illinois, and Pennsylvania have active litigation.
Different evidentiary rules in state courts allow cases that federal courts rejected.
How long does the Zantac lawsuit process take?
Most Zantac cases take two to four years from filing to resolution.
Initial filing requires six to eleven weeks after attorney consultation.
Settlement timing depends on trial outcomes and defendant negotiations.
Take Action Now
The Zantac lawsuit remains open for qualified cancer victims in 2026. State courts provide a real path to compensation even after federal cases were dismissed.
Your window to file may close soon depending on where you live. Statutes of limitations do not wait. Gather your medical records, pharmacy history, and any Zantac purchase evidence you can find.
Contact a qualified Zantac attorney for a free case evaluation. The consultation costs nothing. Missing your deadline costs everything.
